Spring Co-Op: Immune Regulation in Oncology

BioCT Innovation Commons; Ridgefield (CT); On-site; USD 33,000 - 45,000; Part time

Job summary

Boehringer Ingelheim is seeking a Spring Co-Op in the Immune Regulation group within the Oncology Research department at Ridgefield CT. You will contribute to in vitro cancer immunology work, developing immune suppression assays and translational platforms for evaluating novel therapeutics.

The role offers exposure to cross-functional teams and a collaborative environment. Qualified candidates are graduate students in immunology/oncology with hands-on in vitro assay experience (FACS/ELISA) and a

Qualifications

• Must be a current Master's or Ph.D degree student in good academic standing.
• Enrolled at an accredited college or university for the duration of the co-op.
• GPA 3.0/4.0 preferred.
• Major or minor in immunology, oncology, or cell biology.
• Graduate/advanced degree students must have completed at least 9 credits.

Responsibilities

• Developing and refining tumor tissue dissociation protocols.
• Developing tumor microenvironment-mimetic immune suppression assays.
• Establishing and optimizing tumor cell killing assays.

Skills

Immunology

Oncology

Cell biology

Cell culture

FACS

ELISA

Immune cell isolation

CRISPR validation

Tumor cell killing assays

Problem solving

Scientific writing

Record keeping

Oral communication

Teamwork

Education

Master's or PhD student

Job description

Boehringer Ingelheim is seeking a Spring Co-Op in the Immune Regulation group within the Oncology Research department at Ridgefield CT. You will contribute to in vitro cancer immunology work, developing immune suppression assays and translational platforms for evaluating novel therapeutics.

The role offers exposure to cross-functional teams and a collaborative environment. Qualified candidates are graduate students in immunology/oncology with hands-on in vitro assay experience (FACS/ELISA) and a